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We analyzed the variability and established the phylogeny of the L1 capsid protein gene of 33 isolates of human papillomavi-
rus type 5 (HPV5) obtained from epidermodysplasia verruciformis patients from different continents. By comparing the
sequences of a 419-bp fragment with those published for two Japanese isolates, we found 12.9% variable nucleotide
positions, defining 25 variants with mutation rates ranging from 0.2 to 8.8%. Such a high intratypic diversity is unusual
among HPVs. Nine of the 139 encoded amino acids were variable and 12 protein variants were identified. Fifteen of the
16 substitutions observed were clustered in two short regions. A 9-amino-acid insert, already reported for the Japanese
HPV5b isolate, was found within one of the regions in five isolates. Our data support that the insert arose from the duplication
of a 30-nucleotide sequence. Phylogenetic trees distributed the DNA variants into three subtypes (a to c) with a divergence
higher than 4.5% and allowed the recognition of European and African lineages. By contrast with the trees based on the
HPV5 E6 gene, HPV5a DNA variants and the HPV5b variants lacking the insert constituted a single group in the L1 amino
acid tree, probably reflecting different levels of structural constraints for the HPV5 L1 and E6 proteins. In that respect, the
short variable L1 sequences should represent less constrained regions. q 1996 Academic Press, Inc.
INTRODUCTION Phylogenetic trees constructed from nucleotide or amino
acid sequences disclosed a grouping of HPV genotypes
Human papillomaviruses (HPVs) constitute a large reflecting their cutaneous or mucous tropism, their patho-
group of DNA viruses causing a variety of epithelial prolif- genicity, and their oncogenic potential (Chan et al., 1995;
erations of the squamous epithelia of the skin and mu- Van Ranst et al., 1993).
cous membranes (Orth, 1994; zur Hausen and de Villiers, Evidence for an intratypic diversity of oncogenic HPV
1994). Among the 77 HPV genotypes characterized so types has recently been disclosed. Comparison of nucle-
far (zur Hausen, 1995), some are etiologically associated otide sequences of different genomic regions among a
with the carcinomas of the uterine cervix (mainly HPV16 large number of HPV16 and HPV18 isolates demon-
and 18) and others with the cutaneous carcinomas ob- strated the existence of numerous stable DNA variants
served in patients suffering from epidermodysplasia ver- (Chan et al., 1992; Ho et al., 1993; Icenogle et al., 1991,
ruciformis (mainly HPV5) (Orth, 1987; zur Hausen and de 1995; Ong et al., 1993; Pushko et al., 1994; Smits et al.,
Villiers, 1994). HPV genotypes were first distinguished 1994; Yamada et al., 1995). The amount of variable nucle-
on the basis of a cross-hybridization less than 50% under otide positions among HPV16 isolates was found to vary
the most stringent conditions. A more recent definition, between 2.2% for the L1 ORF and 4.9% for the long control
grossly equivalent, is that genotypes share less than 90% region (LCR), and the maximum pairwise divergence in
identical nucleotides in the open reading frames (ORFs) the coding regions did not exceed 1.2% for the E6 ORF,
encoding the viral oncoproteins (E6 and E7 ORFs) and 1.3% for the L1 ORF, and 2.4% for the L2 ORF (Icenogle
the major capsid protein (L1 ORF). HPV isolates sharing et al., 1995; Yamada et al., 1995). A higher degree of
more than 98% identical nucleotides are considered vari- intratypic diversity is displayed by HPV types 5 and 8
ants, and a DNA sequence identity in the range of 90 to associated with epidermodysplasia verruciformis (EV)
98% defines subtypes (Bernard et al., 1994; de Villiers, (Deau et al., 1991, 1993). This rare disease is a geneti-
1994; Deau et al., 1993; Longuet et al., 1996; Orth, 1994). cally conditioned abnormal susceptibility both to cuta-
neous infection by a subgroup of specific, phylogeneti-
cally related HPV types that are innocuous for the general1 To whom correspondence and reprint requests should be ad-
population and to the oncogenic potential of some ofdressed at Unite´ Mixte Institut Pasteur–INSERM U190, Institut Pasteur,
them, mostly HPV5 (Majewski and Jablonska, 1995; Orth,25 rue du Docteur Roux, 75724 Paris Cedex 15, France. Fax: 33.1.45
68.89.66. 1987; Orth et al., 1979). Comparison of 13 HPV5 isolates
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disclosed a great variability in the 3* end of the LCR and sitions 6124 to 6582 were obtained by the polymerase
chain reaction (PCR) technique with primers correspond-in the E6 gene, affecting 13.3 and 11% of the nucleotide
positions, respectively, with a maximal divergence of ing to the nucleotide positions 6124 to 6143 (5*-CAACAC-
AGAGTATTTCGCCT) and 6563 to 6582 (5*-TAAACTGAC-8.8% between variants (Deau et al., 1993). Phylogenetic
analysis of HPV5 variants distributed them into three sub- ATCTGATCTAC). PCR reaction mixtures contained 100
to 500 ng of total cellular DNA, 50 mM KCl, 10 mM Tris–types, designated a, b, and c (Deau et al., 1993).
The functional significance of the intratypic variability HCl (pH 8.3), 100 mM each deoxynucleoside triphos-
phate, 1.5 mM MgCl2 , 25 pmol of each primer, and 2 Uof HPV genotypes remains poorly understood. No evi-
dence for distinct HPV16 serotypes has been obtained of Thermus aquaticus DNA polymerase (Perkin–Elmer
Cetus Instruments, Emeryville, CA). Mixtures were incu-so far (Cheng et al., 1995; Yaegashi et al., 1993). There
is some evidence, however, that the variability of the E6 bated at 1007 for 5 min for DNA denaturation. Subse-
quently, 30 cycles of amplification were performed withprotein constitutes a mechanism by which tumor cells
escape immune surveillance (Ellis et al., 1995). Due to its a PCR processor (Hybaid, Ltd.) as previously described
(Deau et al., 1993). After Klenow fragment of DNA poly-great genetic heterogeneity compared to HPV16, HPV5
constitutes a valuable model to analyze the genetic diver- merase I was used for end-filling, the fragments were
inserted by blunt ligation at the unique SmaI site of asity and the evolution of HPV genotypes and to investi-
gate to which extent this diversity affects the biological pBluescript plasmid (Stratagene GmbH, Heidelberg).
properties of the variants.
DNA sequencingAs a prerequisite to the study of the antigenic variability
of the major capsid protein, we analyzed the genetic diver-
For each HPV5 isolate, sequencing was performed on
sity of the HPV5 L1 ORF of 33 isolates originating from
both strands of recombinant plasmids by the dideoxy chain
Europe, Africa, and America. We sequenced a 419-bp L1
termination method (Sanger et al., 1977) using the modified
region reported to contain a 27-nucleotide insert in a Japa-
T7 DNA polymerase (Sequenase; United States Biochemi-
nese isolate (Yabe et al., 1991). Our data disclosed a high
cal Corp., Cleveland) under the conditions described by the
degree of nucleotide substitutions, in the range of that ob-
manufacturer. The nucleotide sequence of the L1 fragment
served previously in the 3* end of the LCR and the E6 gene
of HPV5 E1, NAf1, SAm4, E10, and E11 isolates was deter-
(Deau et al., 1993). We also demonstrate the existence of
mined on full-length cloned DNA with primers used for
a group of phylogenetically related variants containing the
PCR amplification and an internal primer encompassing
27-nucleotide insert. Amino acid changes or insertion oc-
nucleotides 6340 to 6359 in both orientations. The nucleo-
curred in two short sequences that probably correspond
tide sequence of the other isolates was determined with
to less constrained regions of the L1 protein.
M13 oligonucleotide primers complementary to sequences
flanking the insert and the internal L1 primer in both orienta-
MATERIALS AND METHODS tions. Several independent clones (2 to 5) were sequenced
for each PCR product in order to take into account theTissue specimens
possibility of PCR errors. Sequences have been submitted
Scrapings or biopsies were taken from skin flat warts to the Genbank nucleotide sequence database and Acces-
and macules of 31 EV patients originating from different sion Nos. are listed in Table 1.
continents (Table 1). A biopsy of a squamous cell carci-
noma was also obtained from one of these patients (iso- Phylogenetic trees
late E11). Patients 1, 2, 3, 5, 10, 16, 17, 29, and 30 corre-
Pairwise alignments of the DNA and deduced aminospond to patients 1, 7, 8, 10, 6, 2, 3, 4, and 5 in Deau et
acid sequences of HPV5 variants with those of the proto-al. (1993), patients 4 and 6 to patients 1 and 5 in Orth et
type HPV5 (J1) (Zachow et al., 1987) and the subtypeal. (1979), patients 9, 15, and 16 to patients 8, 4, and 5
HPV5b (J2) (Yabe et al., 1991) were performed withoutin Kremsdorf et al. (1984), patient 12 to patient 2 in Guil-
taking into account the 27-nucleotide insert, using thehou et al. (1980), patients 18 and 19 to patients 5 and 6
fast method of Wilbur and Lipman (1983) executed within Lutzner et al. (1984), and patients 26, 27, 28, and 31
the CLUSTAL V option (Higgins et al., 1992), as previouslyto patients 9, 10, 8, and 4 in Rueda (1993).
described (Deau et al., 1993). Multiple alignments were
generated with the same program, and the similarityPolymerase chain reaction
scores were used to construct phylogenetic trees by un-
weighted pair-group maximum-average (UPGMA) analy-The molecular cloning of the DNA of HPV5 E1, NAf1,
SAm4, E10, and E11 isolates has been reported else- sis (Sneath and Sokal, 1973). Results of multiple se-
quence alignments were used to construct HPV5 treeswhere (Deau et al., 1991; Kremsdorf et al., 1982). The
prototypical HPV5 DNA (J1) was kindly provided by R. by the maximum parsimony (DNA PARS) or the maximum
likelihood methods with the PHYLIP 3.4 programs (Phy-Ostrow (University of Minnesota, Minneapolis). The L1
419-nucleotide fragments encompassing nucleotide po- logeny Inference Package) (Felsenstein, 1988). To root
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TABLE 1
Origin and Nomenclature of HPV5 Isolates
Patient Geographic origin Isolate designationa Subtypeb Accession No.c
1 Poland E1 (5a2) a U49465
2 Poland E2 (5a4) a U49463
3d Poland E3 (5a5) a U49462
4d Poland E4 a U49462
5d Poland E5 (5b1) b(/) U49477
6d Poland E6 a U49462
7 Poland E7 a U49466
8 Poland E8 a U49460
9 Poland E9 a U49467
10 France E10 (5a3) a U49461
E11 (5c1) c U49476
11 France E12 a U49462
12 France E13 b(/) U49479
13 France E14 b(/) U49481
14 Spain E15 a U49459
15 Italy E16 b(/) U49478
16 The Netherlands E17 (5a2) a U49464
17 Algeria NAf1 (5b3) b U49469
18 Algeria NAf2 b(/) U49480
NAf3 b U49474
19 Algeria NAf4 b U49468
20 Algeria NAf5 b U49470
21 Senegal WAf1 b U49470
22 Cape Verde Islands WAf2 b U49471
23 French Caribbean FC1 b U49472
24 French Caribbean FC2 b U49473
25 United States NAm1 c U49475
26d Colombia SAm1 a U49466
27d Colombia SAm2 a U49466
28d Colombia SAm3 a U49466
29d Colombia SAm4 (5b2) b U49468
30d Colombia SAm5 (5b2) b U49468
31d Colombia SAm6 b U49468
J1 Japan J1 (5a1) a M17463
J2 Japan J2 (5b) b(/) D90252
a Isolates were designated by letters according to the geographic origin of the patients (E, Europe; NAf, North Africa; WAf, West Africa; FC, French
Caribbean; NAm, North America; SAm, South America; J, Japan) and by numbers, taking into account the chronological order of their characterization
and the familial occurrence of the disease. J1 and J2 correspond to Japanese isolates sequenced by Zachow et al. (1987) and Yabe et al., (1991),
respectively. Previous phylogenetic classification (Deau et al., 1993) is given in parentheses.
b Deduced from the phylogenetic analysis shown in Fig. 4A. (/) indicates the presence of the 27-nucleotide insert.
c Assigned to the sequences of the L1 419-bp fragment upon submission to the Genbank database.
d Patients 3 to 5, 26 to 28, and 29 to 31 are siblings from three different families. Patient 6 is the daughter of patient 5.
the trees, HPV47 sequences (Kiyono et al., 1990) were Europe (16 cases, mainly from Poland and France), North
Africa (4 cases), West Africa (2 cases), French Caribbeanused as an outgroup. Bootstrap resampling allowed esti-
mation of the confidence limits of tree grouping which (2 cases), North America (1 case), and South America (6
were significant at the 95% level (Felsenstein, 1988). cases). Isolates were designated by letters and numbers,
taking into account the geographic origin of patients, the
chronological order of their identification, and the familialRESULTS
occurrence of the disease (Table 1). Previous sequence
A high level of nucleotide substitutions in the HPV5
analysis of the 3* end of the LCR and of the entire E6
L1 ORF
ORF of 10 of these isolates had distributed them into
three subtypes, HPV5 a, b, and c (Deau et al., 1993). WeThe sequence of a 419-bp segment localized in the 5*
compared the L1 sequences with those published forhalf of the HPV5 L1 ORF (nt 6144 to 6562; Zachow et al.,
two Japanese isolates corresponding to the prototypical1987) was established for 33 HPV5 isolates obtained
from 31 EV patients (Table 1). Patients originated from HPV5 (Zachow et al., 1987) and to the HPV5b subtype,
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FIG. 1. Nucleotide sequence variations in the L1 ORF among HPV5 variants. Nucleotide positions at which variations were observed are written
vertically on the top, as well as the nucleotides 6328 and 6329 flanking the 27-nucleotide insert (i) found in six isolates. The numbering of nucleotides
refers to the nucleotide sequence of the prototypical HPV5 isolate (Zachow et al., 1987), as corrected in this study (J1). Isolates (left column) are
described in Table 1. Sequence data for the J2 isolate are from Yabe et al. (1991). Only substitutions observed in the variants are indicated. Bars
on the left indicate identical isolates. The protein variant (a to l) corresponding to each isolate (Fig. 4C) is given on the right. Variable nucleotide
positions within the same codon are underlined and amino acid changes resulting from nonsynonymous mutations are indicated at the bottom.
an isolate reported to contain an additional 27-nt se- tions and 16 substitutions. Moreover, five isolates were
found to harbor a 27-nucleotide insert (Fig. 2). Withoutquence in this region (Yabe et al., 1991). These two Japa-
nese isolates will be referred to as J1 and J2, respectively. taking into account this insert, 23 HPV5 variants were
identified, in addition to J1 and J2 variants (Fig. 1). Muta-All isolates, including J2, were found to differ from the
prototypical HPV5 J1 by three C r G nucleotide substitu- tions involving C r T or T r C transitions accounted for
39% of the nucleotide changes, and CC r TT doubletions at positions 6175, 6265, and 6502, corresponding
to three amino acid changes (Pro87 r Ala; Arg117 r Gly; mutations characteristic of UV-induced mutagenesis
(Brash et al., 1991) were not observed.Gln196 r Glu). This difference was no longer found upon
resequencing this L1 region of the original J1 DNA clone Pairwise comparison revealed nucleotide substitution
rates ranging from 0.2% (a single mutation) to 8.8% (37(a generous gift from R. Ostrow). We shall refer hereafter
to the corrected sequence as the prototypical HPV5. Nu- mutations). Two patients (cases 10 and 18) were found
infected with two variants, and two variants were detectedcleotide sequence comparison revealed a high level of
nucleotide substitutions among isolates (Fig. 1). Fifty- in a Polish family with four affected members (cases 3 to
6) (Table 1). Some variants were found in patients fromfour (12.9%) of the 419 nucleotide positions were found
variable and 58 nucleotide substitutions were observed. different countries of the same continent (e.g., patients in-
fected with E3, 4, 6, and 12 isolates) or from different conti-A hot spot of mutations was located between nucleotides
6433 and 6462, with 13 (43%) variable nucleotide posi- nents (patients infected with E7, SAm1, 2, and 3 isolates)
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FIG. 2. Sequence alignment of the HPV5 variants in the L1 region containing a 27-nucleotide insert. The J2, E5, E13, E14, E16, and NAf2 sequences
were aligned with that of the prototypical J1. The position of the insert reported by Yabe et al. (1991) in the J2 isolate is shown by a shadowed box
above the J1 sequence. According to the alignment presented, the additional sequences (small letters) are likely to have resulted from a duplication
of the 30-nucleotide sequence downstream of position 6328, by a slipped mispairing mechanism (Roth et al., 1985) involving two imperfect repeats
R1 and R2. The direct repeats (R1, r) thus created, and theoretically allowing the deletion of the insert, are also shown. Mutations in the duplicated
sequences are underlined. The alignments of the 27-nucleotide insert and of the deduced 9-amino-acid sequence (italics) of the J2 and E5 isolates
with the downstream sequences (bold) are given at the bottom. The three amino acid changes (stars) resulting from the 3-nucleotide deletion and
from the two mutations shared by all variants are indicated, as well as the amino acid changes (parentheses) observed among variants.
(Table 1; Fig. 1). This points to the stability and the world- 2). From the alignment of the nucleotide sequences of
all six variants with that of J1, it is likely that the insertwide distribution of HPV5 variants.
maps at nucleotide position 6328 and results from a du-
Two short variable amino acid sequences in the plication of the immediately downstream 30 nucleotides
HPV5 L1 protein (nucleotides 6329 to 6358). In the variants containing the
insert, the 5 nucleotides following position 6328 (CATTT,
Sixteen of the 58 nucleotide changes were nonsynony-
R1) are perfectly repeated 27 nucleotides downstream,
mous mutations and resulted in 16 amino acid substitutions
and an imperfect repeat (CCTTT, R2) is found 30 nucleo-
involving 9 (6.4%) of the 139 amino acid positions (amino
tides farther. This would fit with the generation of an
acids 77 to 215) (Figs. 1 and 3). Pairwise comparisons of
overlapping duplication of 30 nucleotides during viral
the deduced L1 amino acid sequences of the 25 DNA
DNA replication by a slipped mispairing mechanism, ac-
variants disclosed 12 protein variants, designated a to l.
cording to the model described by Roth et al. (1985).
Variants differed by 1 to 6 amino acid changes (Fig. 3).
Compared with the 30-nucleotide sequence, all inserts
Amino acid changes affecting 4 positions were nonconser-
share a deletion of 3 nucleotides affecting codons 143
vative, namely, Gln145 r Leu, Asp146 r Asn, Glu177 r
and 144 and two mutations, leading to the loss of the
Lys, and Thr182 r Pro, Leu, Val, or Ile (Risler et al., 1988).
residue Arg144 and to three amino acid changes (Fig.
All variable residues but 1 were located in two short se-
2). Two variants (E5 and NAf2) share the same insert as
quences of 10 and 12 amino acids. The 10-amino-acid
J2 while the others harbor mutations at positions 6328
sequence (amino acids 173 to 182) showed 12 substitutions /10 (E13, E14, and E16), /17 (E14), and /24 (E16), two
affecting 5 residues. The 12-amino-acid sequence (amino
of them leading to amino acid changes (Figs. 2 and 3).
acids 135 to 146) contained 3 variable residues and, for
The first 15 nucleotides (r) in the duplication are directly
variants h to j, an insertion of 9 amino acids (Fig. 3). When
repeated in the downstream sequences (Fig. 2) and this
the HPV5 L1 amino acid sequences were aligned with that
repeat could allow the deletion of the insert by a similar
of HPV47 (Kiyono et al., 1990), the type most related to
slipped mispairing mechanism.
HPV5 in this region, only 8 (5.7%) differences were found.
Five of them (3 amino acid changes and a deletion of 2
The phylogenetic analysis of the HPV5 L1 variantsresidues) were located in regions homologous to the two
HPV5 variable sequences. Both regions are the least con-
Multiple alignments of the nucleotide and deducedserved in the aligned HPV16 L1 sequence (Seedorf et al.,
amino acid sequences of the L1 fragment were per-1985) (Fig. 3).
formed without taking into account the insert, and phylo-
genetic trees of the HPV5 variants were constructed byA subgroup of HPV5 L1 variants with a 27-nucleotide/
a distance matrix approach (UPGMA) (Sneath and Sokal,9-amino-acid insert
1973), the maximum parsimony analysis (DNA PARS),
and the maximum-likelihood method (Felsenstein, 1988).A 27-nucleotide insert was found in variants obtained
from a North African (NAf2) and four European (E5, E13, The L1 nucleotide trees distributed the isolates into three
groups (subtypes a, b, and c) differing by more than 4.5%E14, and E16) patients (Fig. 2). A similar insert had been
reported by Yabe et al. (1991) to be present in the HPV5b of nucleotides, as illustrated in Fig. 4A. The HPV5a L1
variants include 12 of the 17 European isolates, a variant(J2) genome at position 6349 or 6350 (corresponding to
nucleotide 6343 or 6344 in the protypical J1 HPV5) (Fig. found in three siblings from Colombia, and the J1 isolate.
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FIG. 3. Amino acid variations in the L1 protein among HPV5 variants. The L1 amino acid sequence encoded by the 419-bp fragment (amino acid
positions 77 to 215) of the prototypical HPV5 (protein variant a) was deduced from the nucleotide sequence reported by Zachow et al. (1987), as
corrected in this study. Substitutions found in the protein variants b to l are indicated. The sequence of the 9 amino acids inserted at position 138
in the J2 isolate (protein variant h) and amino acid changes observed in variants i and j are presented above the sequences. The two variable
regions are shadowed. The alignment of L1 amino acid sequences of HPV 47 (Kiyono et al., 1990) and HPV16 (Seedorf et al., 1985) are shown
below the HPV5 sequences.
The HPV5b L1 variants are split into two subgroups dif- Glu177 r Lys) (Fig. 3). In addition, the E5 and E16 isolates
encoding the variant protein i differ by two amino acidsfering by less than 2% of nucleotides. One corresponds
to isolates from 5 of the 6 African patients, 2 French within the insert. The most divergent HPV5c DNA variants
encode two closely related protein variants (k, l) charac-Caribbean patients of African origin, and 3 Colombian
siblings. The other subgroup contains all variants with terized by four specific amino acid changes (Fig. 3).
The nucleotide sequence of the entire E6 ORF (471 nu-the 27-nucleotide insert and 1 (NAf3) lacking this insert.
All the variants with the insert share two specific muta- cleotides) was established previously for 10 of the 33 iso-
lates of this study (Deau et al., 1993). The trees constructedtions at nucleotide positions 6350 and 6445 (Fig. 1). The
HPV5c L1 variants include a French and a North Ameri- from these sequences distributed the variants into three
groups corresponding to those found for the L1 DNA vari-can isolate very closely related but greatly divergent from
the others (Fig. 4A). ants, with more than 4.5% nonidentical nucleotides. (Figs.
4A and 4C). However, by contrast with the L1 variants,The phylogenetic trees based on the deduced amino
acid sequences also distributed the 12 L1 protein vari- the HPV5 E6 DNA and protein variants shared the same
phylogenetic grouping (Figs. 4C and 4D).ants into three groups. However, striking differences
were observed for HPV5a and b isolates when nucleotide
and amino acid L1 trees were compared (Figs. 4A and DISCUSSION
4B). The 10 HPV5a DNA variants and the 7 HPV5b DNA
variants lacking the insert encode closely related L1 pro- The analysis of the variability of a 419-bp sequence
within the 5* half of HPV5 L1 ORF has disclosed antein variants that are clustered into a single group and
differ from each of the others by only one (protein variants intratypic diversity as high as that of the E6 ORF and the
3* region of the LCR, which had previously allowed usa to f) or two (variant g) amino acid changes. The proto-
typical J1 and the E15 HPV5a isolates encode the same to distinguish three subtypes, HPV5 a, b, and c (Deau
et al., 1993). Fifty-four (12.9%) nucleotide positions wereL1 protein variant as most non-European HPV5b isolates
(Figs. 1, 4A, and 4B). The HPV5 variants with the L1 found variable and 23 HPV5 L1 DNA variants were identi-
fied among the 33 isolates studied, in addition to theinsert constitute a distinct group and encode 3 related
L1 protein variants (h to j) that share two specific, non- Japanese variants J1 and J2 (Zachow et al., 1987; Yabe
et al., 1991). The most divergent isolates (variants E10conservative amino acid changes (Gln145 r Leu and
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FIG. 4. Phylogenetic trees of HPV5 variants. Trees were generated by use of the UPGMA distance matrix method from the alignment of the
sequences of a 419-nucleotide fragment in the L1 ORF of 35 HPV5 isolates (nucleotide positions 6144 to 6562), without taking into account the 27-
nucleotide insertion (A), and the deduced 139-amino acid sequences (B), and from the nucleotide sequences of the E6 ORF (471 nucleotides) of
12 of the 35 HPV5 isolates (C), and the deduced 157-amino-acid sequences (D) (Deau et al., 1993; Yabe et al., 1991; Zachow et al., 1987). The
HPV47 nucleotide sequence (Kiyono et al., 1990) was used as an outgroup. Isolates are designated as described in Table 1 and HPV5b isolates
with the L1 insert are indicated by a star. HPV5b isolates included in both the L1 and the E6 trees are shadowed. The 12 L1 and the 6 E6 protein
alleles are designated a to l and a to f, respectively.
and E11 found in the same French patient) show the 1987). The relatively low frequency (39%) of C r T or T r
C transitions and the absence of CC r TT double muta-same percentage (8.8%) of nonidentical nucleotides in
the E6 and L1 ORFs. The HPV5 L1 DNA variants are tions, pathognomonic of UVB-induced mutations (Brash
et al., 1991), do not support a major role of ultravioletstable and have a worldwide distribution since some of
them were found in patients originating from different radiations in the evolution of HPV5.
The phylogenetic grouping of HPV5 L1 DNA variantscountries of the same continent or from different conti-
nents. The intratypic diversity of HPV5 is greater than fits with their geographic origin, resulting in the identifica-
tion of three lineages, a European lineage including thethat of HPV16. Only 42 variable nucleotide positions have
been identified in the HPV16 L1 ORF (Yamada et al., majority of the variants of HPV5a subtype, an African
lineage comprising the majority of HPV5b isolates, and1995), and variants were found to display a maximum
pairwise difference of 1.2 and 1.3% for the L1 and E6 a third lineage, probably of European origin, correspond-
ing to the HPV5c subtype. The phylogenetic analysis ofORFs, respectively (Icenogle et al., 1995; Yamada et al.,
1995). If one admits that all HPV genotypes share the genital oncogenic HPV types has also disclosed the exis-
tence of African, European, Asian, and Asian-Americansame slow evolution rate, it would mean that HPV5
emerged before HPV16. Another hypothesis would be lineages of this virus (Bernard et al., 1994; Ho et al.,
1993; Ong et al., 1993). In view of the greater geneticthat HPV5 evolved more rapidly, under the influence of
the mutagenic effect of ultraviolet B radiations. HPV5 heterogeneity of African HPV16 variants, it has been pos-
tulated that these viruses emerged in Africa, at leastreplicates in EV patients in very flat, abnormally keratin-
ized, skin lesions located in sun-exposed areas (Orth, 200,000 years ago, and coevolved with the major human
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races (Bernard et al., 1994). In contrast to HPV16, the and 482 to 510 (Myers et al., 1995). These regions are
also the most variable when multiple papillomavirus phy-most divergent HPV5 variants (E10 and E11) are of Euro-
pean origin, which could suggest that HPV5 emerged logenetic groups are compared (Myers et al., 1995). In-
sertions or deletions of 1 to 4 amino acids responsibleoutside Africa, in an ancestor of Homo sapiens who mi-
grated to Europe and Asia (Wanpo et al., 1995). for the different sizes of the L1 proteins of EV HPVs
(ranging from 506 to 518 amino acids) are found withinThe percentage (72.5%) of silent nucleotide substitu-
tions observed within the L1 ORF is higher than that these sequences. The two regions of intratypic variability
found in this study correspond to two of these regions,(59.3%) previously found for the HPV5 E6 ORF (Deau et
al., 1993). It is likely that this reflects the existence of the plasticity of which seems compatible with the preser-
vation of the functional integrity of the L1 protein.negative selection pressures to comply with the struc-
tural and functional constraints imposed by capsomer The observed variability could also reflect an immuno-
logical selective pressure. Antibodies reacting with con-formation and capsid assembly. This could explain why
HPV5 variants belonging to two distinct groups in the L1 formational or linear epitopes of the L1 protein are raised
during natural HPV infections (Cheng et al., 1995; Chris-nucleotide phylogenetic tree (subtype a and subtype b
without the insert) encode a family of closely related L1 tensen et al., 1992; Dillner et al., 1995; Kirnbauer et al.,
1994). Immunization with L1 fusion proteins or with virus-proteins, whereas the corresponding E6 DNA and protein
variants remain distributed into two subtypes (Fig. 4). An like particles obtained by self-assembly of the L1 protein
induces neutralizing antibodies (Breitburd et al., 1995;example of a mutation most probably counterselected is
the His202 r Asp change found in a cervical cancer Lin et al., 1992; Roden et al., 1994). So far, the existence
of distinct serotypes has never been demonstrated forspecimen (Seedorf et al., 1985), responsible for the ineffi-
cient self-assembly of the HPV16 L1 protein into a capsid any of the known HPV genotypes (Galloway, 1994). By
using virus-like particles in an ELISA test, it has been(Kirnbauer et al., 1993).
The analysis of the intratypic diversity of the HPV5 L1 shown recently that the most divergent HPV16 L1 DNA
variants, with L1 proteins differing by 7 amino acids, areORF has further substantiated a feature characteristic of
the evolution of the major L1 capsid protein of papillo- serologically cross-reactive (Cheng et al., 1995). Com-
pared with that of HPV16, the intratypic variability of themaviruses, i.e., the existence of short regions allowing
the accumulation of amino acid substitutions and inser- HPV5 L1 protein involves a greater number of variable
amino acids, a higher maximum pairwise divergence be-tions or deletions. Fifteen of the 16 amino acid substitu-
tions observed are localized into two short sequences tween variants (21 amino acids for E10 and E11 variants;
M. Kawase et al., unpublished results) and, even, the(amino acids 135 to 146 and 173 to 182). In certain HPV5b
variants originating from North Africa and Europe, one insertion of 9 amino acids in some of the variants. By
using virus-like particles obtained by self-assembly ofof these sequences contains a 9-amino-acid insertion
similar to that previously described in a Japanese variant L1 proteins of different HPV5 variants, we are currently
investigating whether such a variability interferes with(Yabe et al., 1991). We postulate that this insertion arose
from the duplication of a 30-nucleotide sequence gener- capsid morphogenesis and stability and results in varia-
tions of the antigenic properties of viral particles.ated by a slipped mispairing mechanism (Roth et al.,
1985; Streisinger et al., 1966). It is tempting to assume
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